Clinical Liver Disease

1.7(top 50%)

impact factor

1.0K(top 20%)

papers

6.8K(top 20%)

citations

31(top 20%)

h-index

1.8(top 50%)

impact factor

1.3K

all documents

7.7K

doc citations

47(top 20%)

g-index

Top Articles

#	Title	Journal	Year	Citations
1	Global Epidemiology of Chronic Liver Disease	Clinical Liver Disease	2021	247
2	Update on Prevention, Diagnosis, and Treatment of Chronic Hepatitis B: AASLD 2018 Hepatitis B Guidance	Clinical Liver Disease	2018	187
3	Nonalcoholic Fatty Liver Disease and Recent Guideline Updates	Clinical Liver Disease	2021	108
4	Nonalcoholic fatty liver disease: Definitions, risk factors, and workup	Clinical Liver Disease	2012	95
5	Recent trends in the epidemiology of alcoholic liver disease	Clinical Liver Disease	2013	80
6	Standard liver tests	Clinical Liver Disease	2016	69
7	The epidemiology of nonalcoholic steatohepatitis	Clinical Liver Disease	2018	64
8	Bile Acid Biology, Pathophysiology, and Therapeutics	Clinical Liver Disease	2020	61
9	Con: Liver Biopsy Remains the Gold Standard to Evaluate Fibrosis in Patients With Nonalcoholic Fatty Liver Disease	Clinical Liver Disease	2019	60
10	Congestive hepatopathy	Clinical Liver Disease	2016	59
11	Patterns of necrosis in liver disease	Clinical Liver Disease	2017	53
12	Risk factors for hepatocellular carcinoma	Clinical Liver Disease	2012	52
13	Epidemiology of Alcohol Use and Alcoholic Liver Disease	Clinical Liver Disease	2019	52
14	Interrelationship Between Coronavirus Infection and Liver Disease	Clinical Liver Disease	2020	52
15	Diagnostic challenges of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis	Clinical Liver Disease	2018	51
16	Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases	Clinical Liver Disease	2019	49
17	Histopathology of alcoholic liver disease	Clinical Liver Disease	2013	47
18	Reactivation of Hepatitis B Virus: A Review of Clinical Guidelines	Clinical Liver Disease	2020	47
19	Epidemiology of Hepatitis B Virus Infection in the United States	Clinical Liver Disease	2018	44
20	Ectopic varices	Clinical Liver Disease	2012	39
21	Role of special stains in diagnostic liver pathology	Clinical Liver Disease	2013	39
22	The Association Between Nonalcoholic Fatty Liver Disease and Cardiovascular Disease Outcomes	Clinical Liver Disease	2018	39
23	Pain management in patients with cirrhosis	Clinical Liver Disease	2018	39
24	Pyogenic liver abscess	Clinical Liver Disease	2015	38
25	Biomarkers for monitoring alcohol use	Clinical Liver Disease	2016	38
26	Epidemiology of Pediatric Nonalcoholic Fatty Liver Disease	Clinical Liver Disease	2021	38
27	Nonalcoholic fatty liver disease: Indications for liver biopsy and noninvasive biomarkers	Clinical Liver Disease	2012	37
28	The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases	Clinical Liver Disease	2018	37
29	Chronic Liver Disease and COVID‐19: Alcohol Use Disorder/Alcohol‐Associated Liver Disease, Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Autoimmune Liver Disease, and Compensated Cirrhosis	Clinical Liver Disease	2020	37
30	Association of Sarcopenia and NAFLD: An Overview	Clinical Liver Disease	2020	36
31	Preeclampsia‐induced Liver Dysfunction, HELLP syndrome, and acute fatty liver of pregnancy	Clinical Liver Disease	2014	35
32	Microscopic anatomy of the liver	Clinical Liver Disease	2013	34
33	Silymarin in the treatment of liver diseases: What is the clinical evidence?	Clinical Liver Disease	2016	34
34	What Are the Optimal Liver Transplantation Criteria for Hepatocellular Carcinoma?	Clinical Liver Disease	2019	34
35	A brief history of the treatment of viral hepatitis C†	Clinical Liver Disease	2012	32
36	Model for end‐stage liver disease exception points for treatment‐responsive hepatocellular carcinoma	Clinical Liver Disease	2016	31
37	Cannabinoids in liver diseases	Clinical Liver Disease	2016	31
38	An update on the pharmacological treatment of nonalcoholic fatty liver disease: Beyond lifestyle modifications	Clinical Liver Disease	2018	31
39	AASLD/IDSA HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C	Clinical Liver Disease	2018	31
40	SGLT2 inhibitors and cirrhosis: A unique perspective on the comanagement of diabetes mellitus and ascites	Clinical Liver Disease	2018	31
41	Nonalcoholic Fatty Liver Disease and Cardiovascular Disease	Clinical Liver Disease	2021	31
42	Normal liver anatomy	Clinical Liver Disease	2013	30
43	Telemedicine and Telehepatology During the COVID‐19 Pandemic	Clinical Liver Disease	2020	30
44	Bacterial infections in cirrhosis: A growing problem with significant implications	Clinical Liver Disease	2013	29
45	Elastography to assess the stage of liver fibrosis in children: Concepts, opportunities, and challenges	Clinical Liver Disease	2017	29
46	Epidemiology of Hepatitis C	Clinical Liver Disease	2018	29
47	Treatment for Advanced Hepatocellular Carcinoma: Current Standard and the Future	Clinical Liver Disease	2019	29
48	SARS‐CoV‐2 and the Liver: Considerations in Hepatitis B and Hepatitis C Infections	Clinical Liver Disease	2020	29
49	Altered Microbiota in Cirrhosis and Its Relationship to the Development of Infection	Clinical Liver Disease	2019	28
50	Primary Sclerosing Cholangitis: Epidemiology, Genetics, Diagnosis, and Current Management	Clinical Liver Disease	2020	28

Scientometrics

Overviews

Citing Bodies

Clinical Liver Disease

Top Articles